Source:http://linkedlifedata.com/resource/pubmed/id/12084535
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2002-6-26
|
pubmed:abstractText |
The viability of Cryptosporidium parvum after exposure to peptide antibiotics was studied by two different methods, a cell culture system and a double fluorogenic staining. The peptides KFFKFFKFF and IKFLKFLKFL exerted high cytotoxic effects on sporozoites, as demonstrated by cell cultures (complete inhibition after 60 min at 100 microg/ml) and flow cytometry (30% after 20 min at 100 microg/ml), but did not affect consistently the oocysts. Clarithromycin and rifabutin demonstrated less activity against sporozoites but higher activity against oocysts (30% after 180 min at 10 microg/ml). The combination between peptides and azithromycin or rifabutin exerted the highest activities.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0196-9781
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1015-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12084535-Amino Acid Sequence,
pubmed-meshheading:12084535-Animals,
pubmed-meshheading:12084535-Clarithromycin,
pubmed-meshheading:12084535-Cryptosporidium parvum,
pubmed-meshheading:12084535-Drug Evaluation, Preclinical,
pubmed-meshheading:12084535-Drug Interactions,
pubmed-meshheading:12084535-Flow Cytometry,
pubmed-meshheading:12084535-Oocysts,
pubmed-meshheading:12084535-Peptides,
pubmed-meshheading:12084535-Rifabutin,
pubmed-meshheading:12084535-Sporozoites
|
pubmed:year |
2002
|
pubmed:articleTitle |
In vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity.
|
pubmed:affiliation |
Clinica Malattie Infettive, c/o Ospedale Regionale, Via Conca, Ancona, Italy. anconacmi@interfree.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|